Sysmex adds new single-color, monoclonal antibodies to CyFlow line
Available in wide range of fluorochromes for research use only. Read More »
Available in wide range of fluorochromes for research use only. Read More »
The decision by the FDA was done under accelerated approval with continued approval dependent on consequent trials verifying the clinical benefit of BLINCYTO. Read More »
The Journal of Community and Supportive Oncology recently published a study that presented two key research findings dealing with treatment options for breast cancer. Read More »
Agreement gives Amgen global development and commercial rights to BI 836908 (AMG 420). Read More »
Adding Prolia to glucocorticoid therapy increases bone mineral density. Read More »
Will present 11 abstracts at the conference in Rome on Aug. 27-31. Read More »
MRG anticipates improvements in customer and patient billing process, regulatory compliance and claims management. Read More »
Walgreens this week announced the launch of its kiosks designated for the safe disposal of medications in Iowa. Read More »
Walgreens recently announced that 45 of its locations in Illinois have installed drug take-back kiosks as part of the company’s safe medication disposal kiosk program, designed to provide a safe, convenient means for prescription disposal. Read More »
Proteostasis Therapeutics Inc. recently announced the successful completion of an important preclinical goal in its partnerships with Astellas Pharma Inc. Read More »
DigiTx Partners, a digital health investment firm, recently resulted from a three-way partnership between San Francisco’s DigiTx Partners LLC , Tokyo-based Astellas Pharma Inc. and Boston-based MPM Capital Inc. Read More »
Abbott has introduced its line of next-generation systems, call Alinity. Read More »
Amgen and Advaxis has announced the finalization of a worldwide agreement for the development and commercialization of Advaxis’ ADXS-NEO, a novel, preclinical investigational immunotherapy developed for the treatment of cancer. Read More »
Vaccines available daily; insurance may cover the vaccination. Read More »
Cytokinetics, Inc. and Astellas Pharma, Inc. have announced the expansion of their collaboration in skeletal muscle activators for the inclusion of amyotrophic lateral sclerosis (ALS). Read More »
Franchise partnership agreement signed with Emart last week. Read More »
Arizona Oncology is championing SpaceOar hydrogel, a new tool that has proven to protect patients with prostate cancer from the adverse effects of radiation therapy. Read More »
Arizona Oncology recently broke ground during a ceremony celebrating its new cancer treatment center in East Valley. Read More »
An advisory panel of the Federal Drug Administration (FDA) recently recommended approval of a medication manufactured by Amgen as a feasible alternative product to Humira, a brand created by AbbVie. Read More »
Virginia Cancer Specialists (VCA) has enrolled its first patient in its upcoming advanced lung cancer clinical trial, making it the first center in the world to do so. Read More »